Serum C-reactive protein levels predict survival in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum C-reactive protein levels predict survival in hepatocellular carcinoma

Published:2007-10 Issue:8 Volume:27 Page:1091-1097
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Nagaoka Sakae,Yoshida Takafumi,Akiyoshi Junji,Akiba Jun,Torimura Takuji,Adachi Hisashi,Kurogi Junichi,Tajiri Nobuyoshi,Inoue Kinya,Niizeki Takashi,Koga Hironori,Imaizumi Tsutomu,Kojiro Masamichi,Sata Michio

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2007.01550.x/fullpdf

Reference29 articles.

1. Rising Incidence of Hepatocellular Carcinoma in the United States

2. Estimating the world cancer burden: Globocan 2000

3. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

4. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin-Lymphocyte-Globulin-C-Reactive Protein Index as a Novel Prognostic Biomarker for Hepatocellular Carcinoma after Hepatectomy;Digestive Surgery;2024-07-22

2. C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma;Journal of Inflammation Research;2024-02

3. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients;BMC Cancer;2023-12-05

4. Impact of albumin–lymphocyte–platelet–C‐reactive protein index as a prognostic indicator of hepatocellular carcinoma after resection: Associated with nuclear factor erythroid 2–related factor 2;Hepatology Research;2023-09-06

5. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma;BMC Medical Imaging;2023-05-30